Dr. Vaibhav Sahai, MBBS, MS
Claim this profileUniversity of Michigan Comprehensive Cancer Center
Studies Pancreatic Cancer
Studies Bile Duct Cancer
16 reported clinical trials
28 drugs studied
Area of expertise
1Pancreatic Cancer
Stage IV
Stage III
BRCA1 positive
2Bile Duct Cancer
FGFR2 positive
Stage IV
RAF positive
Affiliated Hospitals
Clinical Trials Vaibhav Sahai, MBBS, MS is currently running
Atezolizumab + Chemotherapy
for Neuroendocrine Carcinoma
This trial is testing a new treatment combining an immune-boosting drug with standard chemotherapy for patients with a specific type of aggressive cancer that has spread. The goal is to help the immune system fight the cancer and use chemotherapy to kill cancer cells.
Recruiting1 award Phase 2 & 310 criteria
Durvalumab + Olaparib with Radiation
for Pancreatic Cancer
This phase I trial tests the safety and tolerability of olaparib in combination with durvalumab and radiation therapy in patients with pancreatic cancer that has spread to nearby tissue or lymph nodes (locally advanced) and cannot be removed by surgery (unresectable). Olaparib is an inhibitor of PARP, an enzyme that helps repair deoxyribonucleic acid (DNA) when it becomes damaged. Blocking PARP may help keep cancer cells from repairing their damaged DNA, causing them to die. PARP inhibitors are a type of targeted therapy. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Radiation therapy uses high energy x-rays, particles, or radioactive seeds to kill cancer cells and shrink tumors. The combination of targeted therapy with olaparib, immunotherapy with durvalumab and radiation therapy may stimulate an anti-tumor immune response and promote tumor control in locally advanced unresectable pancreatic cancer.
Recruiting1 award Phase 125 criteria
More about Vaibhav Sahai, MBBS, MS
Clinical Trial Related6 years of experience running clinical trials · Led 16 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Vaibhav Sahai, MBBS, MS has experience with
- Cisplatin
- Nivolumab
- Capecitabine
- Carboplatin
- Etoposide
- Temozolomide
Breakdown of trials Vaibhav Sahai, MBBS, MS has run
Pancreatic Cancer
Bile Duct Cancer
Biliary Tract Cancer
Pancreatic Adenocarcinoma
Somatostatinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Vaibhav Sahai, MBBS, MS specialize in?
Vaibhav Sahai, MBBS, MS focuses on Pancreatic Cancer and Bile Duct Cancer. In particular, much of their work with Pancreatic Cancer has involved Stage IV patients, or patients who are Stage III.
Is Vaibhav Sahai, MBBS, MS currently recruiting for clinical trials?
Yes, Vaibhav Sahai, MBBS, MS is currently recruiting for 7 clinical trials in Ann Arbor Michigan. If you're interested in participating, you should apply.
Are there any treatments that Vaibhav Sahai, MBBS, MS has studied deeply?
Yes, Vaibhav Sahai, MBBS, MS has studied treatments such as Cisplatin, Nivolumab, Capecitabine.
What is the best way to schedule an appointment with Vaibhav Sahai, MBBS, MS?
Apply for one of the trials that Vaibhav Sahai, MBBS, MS is conducting.
What is the office address of Vaibhav Sahai, MBBS, MS?
The office of Vaibhav Sahai, MBBS, MS is located at: University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan 48109 United States. This is the address for their practice at the University of Michigan Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.